Security key
15117B202
Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (CLDX)
CUSIP: 15117B202
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stock, par value $0.001
- Shares outstanding
- 80,000,000
- Total 13F shares
- 72,931,137
- Share change
- -494,026
- Total reported value
- $2,312,609,200
- Put/Call ratio
- 193%
- Price per share
- $31.72
- Number of holders
- 225
- Value change
- -$9,294,472
- Number of buys
- 119
- Number of sells
- 70
Report period
Q1 2026
Institutions
225
Top holders
10
CLDX full security history
Previous quarter: Q4 2025
Celldex Therapeutics, Inc. SEC filings
Celldex Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 15117B202
Recent filing periods:
Top shareholders of CLDX - Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP |
13F
13D/G
|
Company |
12%
from 13D/G
|
8,079,608
|
$219,442,154 | — | 31 Dec 2025 | |
| Kynam Capital Management, LP |
13F
13D/G
|
Company |
8.8%
from 13D/G
|
5,943,180
|
$161,416,769 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
7.3%
from 13D/G
|
5,451,815
|
$148,071,294 | — | 31 Dec 2025 | |
| FMR LLC |
13F
13D/G
|
Company |
5.6%
from 13D/G
|
4,907,469
|
$133,286,863 | — | 31 Dec 2025 | |
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
|
Vanguard Capital Management |
5.2%
|
3,446,795
|
$109,332,337 | $0 | 31 Mar 2026 | |
| Commodore Capital LP |
13D/G
13F
|
Company |
4.6%
|
3,028,335
|
$78,343,026 | -$8,321,474 | 30 Sep 2025 | |
| STATE STREET CORP |
13F
13D/G
|
Company · STATE STREET CORPORATION |
4.2%
from 13D/G
|
3,397,713
|
$92,281,885 | — | 31 Dec 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13D/G
13F
|
T. Rowe Price Associates, Inc. · Company |
3.6%
|
2,382,701
|
$61,640,475 | -$30,382,633 | 30 Sep 2025 | |
| Point72 Asset Management, L.P. |
13F
13D/G
|
Company |
2.6%
from 13D/G
|
1,758,357
|
$47,756,976 | — | 31 Dec 2025 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
13D/G
|
Company |
2%
from 13D/G
|
1,642,559
|
$44,607,415 | — | 31 Dec 2025 | |
| Bellevue Group AG |
13F
13D/G
|
Company |
1.5%
from 13D/G
|
3,617,669
|
$98,255,890 | — | 31 Dec 2025 | |
| Ph.D. Ronald A. Pepin |
3/4/5
|
SR. VP & CBO |
0.03%
|
20,097
|
$55,869 | — | 15 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
5%
|
4,027,407
|
$109,384,374 | — | 31 Dec 2025 | |
| Deep Track Capital, LP |
13F
|
Company |
2.4%
|
1,900,738
|
$51,624,044 | — | 31 Dec 2025 | |
| BRAIDWELL LP |
13F
|
Company |
2.3%
|
1,858,109
|
$50,466,240 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2%
|
1,627,529
|
$44,211,330 | — | 31 Dec 2025 | |
| Eversept Partners, LP |
13F
|
Company |
1.8%
|
1,434,725
|
$38,967,131 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.5%
|
1,212,705
|
$32,937,068 | — | 31 Dec 2025 | |
| Novo Holdings A/S |
13F
|
Company |
1.5%
|
1,200,000
|
$32,592,000 | — | 31 Dec 2025 | |
| Vestal Point Capital, LP |
13F
|
Company |
1.5%
|
1,165,000
|
$31,641,400 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.3%
|
1,068,131
|
$29,010,438 | — | 31 Dec 2025 | |
| Polar Capital Holdings Plc |
13F
|
Company |
1.3%
|
1,008,163
|
$27,381,707 | — | 31 Dec 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.2%
|
968,616
|
$26,307,611 | — | 31 Dec 2025 | |
| Fisher Asset Management, LLC |
13F
|
Company |
1.2%
|
937,158
|
$25,453,210 | — | 31 Dec 2025 | |
| Elmind Capital, LP |
13F
|
Company |
1.1%
|
865,000
|
$23,493,400 | — | 31 Dec 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
1.1%
|
855,226
|
$23,227,976 | — | 31 Dec 2025 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.87%
|
692,538
|
$18,809,332 | — | 31 Dec 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.83%
|
665,370
|
$18,071,449 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.81%
|
651,716
|
$17,699,718 | — | 31 Dec 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.81%
|
646,767
|
$17,566,192 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.69%
|
550,729
|
$14,957,800 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.69%
|
549,998
|
$14,937,946 | — | 31 Dec 2025 | |
| SEGALL BRYANT & HAMILL, LLC |
13F
|
Company |
0.64%
|
514,531
|
$13,974,662 | — | 31 Dec 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.63%
|
500,127
|
$13,583,449 | — | 31 Dec 2025 | |
| 5AM Venture Management, LLC |
13F
|
Company |
0.62%
|
497,270
|
$13,505,853 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.52%
|
414,888
|
$11,268,359 | — | 31 Dec 2025 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.44%
|
350,000
|
$9,506,000 | — | 31 Dec 2025 | |
| Logos Global Management LP |
13F
|
Company |
0.44%
|
350,000
|
$9,506,000 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.41%
|
326,462
|
$8,866,707 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.36%
|
285,535
|
$7,755,155 | — | 31 Dec 2025 | |
| Redmile Group, LLC |
13F
|
Company |
0.35%
|
283,308
|
$7,694,645 | — | 31 Dec 2025 | |
| Tetragon Partners GP Ltd |
13F
|
Company |
0.3%
|
243,800
|
$6,621,608 | — | 31 Dec 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.3%
|
240,594
|
$6,534,533 | — | 31 Dec 2025 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.3%
|
239,764
|
$6,511,990 | — | 31 Dec 2025 | |
| Corient Private Wealth LLC |
13F
|
Company |
0.29%
|
234,698
|
$6,209,889 | — | 31 Dec 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.29%
|
230,662
|
$6,264,780 | — | 31 Dec 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.25%
|
200,696
|
$5,450,904 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.24%
|
194,552
|
$5,284,020 | — | 31 Dec 2025 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.24%
|
191,074
|
$5,189,570 | — | 31 Dec 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.22%
|
173,677
|
$4,717,067 | — | 31 Dec 2025 |
Institutional Holders of Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (CLDX) as of Q1 2026
As of 31 Mar 2026,
Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (CLDX) was held by
225 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
72,931,137 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, Kynam Capital Management, LP, BlackRock, Inc., FMR LLC, Point72 Asset Management, L.P., VANGUARD CAPITAL MANAGEMENT LLC, STATE STREET CORP, Commodore Capital LP, PRICE T ROWE ASSOCIATES INC /MD/, and Eversept Partners, LP.
This page lists
225
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
183
Q1 2026 holders
225
Holder diff
42
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.